Catalyst Wire Dossier Catalyst Wire Dossier

Glybera

alipogene tiparvovec · Amsterdam Molecular Therapeutics
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Glybera, covering 2011-09-29 to 2017-10-30. Get the full timeline:

Most recent: EMA Expired: Glybera (alipogene tiparvovec) — uniQure biopharma B.V.

See pricing